Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond

Abstract excerpt

Given the multiple differences between mice and men, it was once thought that mice could not be used to model atherosclerosis, principally a human disease. Apolipoprotein E-deficient (apoEKO) mice have convincingly changed this view, and the ability to model human-like plaques in these mice has provided scientists a platform to study multiple facets of atherogenesis and to explore potential therapeutic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adipokines, Inflammation, and Metabolic Diseases
• Share to Atherosclerosis and Cardiovascular Diseases
• Share to Diabetes, Cardiovascular Risks, and Lipoproteins